Bleeding, End Stage Renal Disease
Conditions
Keywords
bleeding, end stage renal disease, antiplatelet therapy, anticoagulant therapy, hemodialysis
Brief summary
This study is examining the risk and protective factors associated with bleeding in the hemodialysis population.
Interventions
None listed
Sponsors
St. Joseph's Healthcare Hamilton
Hamilton Health Sciences Corporation
Study design
Observational model
DEFINED_POPULATION
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
0 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patient is undergoing hemodialysis
Exclusion criteria
* This is an observational study. No
Countries
Canada
Contacts
Primary ContactChristian G Rabbat, MD
Backup ContactCatherine M Clase, MD
Outcome results
None listed